NCT00536770 2007-11-06A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic CancerNovaceaPhase 2 Suspended132 enrolled